blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP0280474

EP0280474 - Macromolecular platinum antitumor compounds [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  03.09.1994
Database last updated on 11.09.2024
Most recent event   Tooltip07.03.1997Lapse of the patent in a contracting statepublished on 23.04.1997 [1997/17]
Applicant(s)For all designated states
JOHNSON MATTHEY, INC.
4 Malin Road Malvern
Pennsylvania 19355 / US
[N/P]
Former [1988/35]For all designated states
JOHNSON MATTHEY, INC.
4 Malin Road
Malvern Pennsylvania 19355 / US
Inventor(s)01 / Serino, Anthony J.
1143 Pynchon Hall Road
West Chester Pennsylvania 19382 / US
02 / Henson, Geoffrey W.
81 Devon Drive
Exton Pennsylvania 19341 / US
03 / Schwartz, David A.
122 Princeton Road
Exton Pennsylvania 19341 / US
04 / Picker, Donald H.
405 Merwyn
Merian Pennsylvania 19066 / US
[1988/35]
Representative(s)Arthur, Bryan Edward, et al
Withers & Rogers Goldings House 2 Hays Lane
London SE1 2HW / GB
[N/P]
Former [1988/35]Arthur, Bryan Edward, et al
Withers & Rogers 4 Dyers Buildings Holborn
London, EC1N 2JT / GB
Application number, filing date88301410.219.02.1988
[1988/35]
Priority number, dateUS1987001871525.02.1987         Original published format: US 18715
[1988/35]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report 
No.:EP0280474
Date:31.08.1988
Language:EN
[1988/35]
Type: A3 Search report 
No.:EP0280474
Date:31.01.1990
Language:EN
[1990/05]
Type: B1 Patent specification 
No.:EP0280474
Date:03.11.1993
Language:EN
[1993/44]
Search report(s)(Supplementary) European search report - dispatched on:EP13.12.1989
ClassificationIPC:A61K47/36, A61K39/395, A61K49/02
[1993/44]
CPC:
A61K47/6803 (EP,US); A61K47/61 (EP,US); A61P35/00 (EP)
Former IPC [1988/35]A61K47/00, A61K39/395, A61K49/02
Designated contracting statesAT,   BE,   CH,   DE,   FR,   GB,   IT,   LI,   LU,   NL,   SE [1988/35]
TitleGerman:Makromolekulare Platin-Antitumorverbindungen[1988/35]
English:Macromolecular platinum antitumor compounds[1988/35]
French:Composés de platine macromoléculaires antitumoraux[1988/35]
Examination procedure21.07.1990Examination requested  [1990/37]
24.06.1991Despatch of a communication from the examining division (Time limit: M06)
29.11.1991Reply to a communication from the examining division
30.01.1992Despatch of a communication from the examining division (Time limit: M04)
03.06.1992Reply to a communication from the examining division
30.07.1992Despatch of a communication from the examining division (Time limit: M04)
04.12.1992Reply to a communication from the examining division
26.01.1993Despatch of communication of intention to grant (Approval: Yes)
05.05.1993Communication of intention to grant the patent
19.07.1993Fee for grant paid
19.07.1993Fee for publishing/printing paid
Opposition(s)04.08.1994No opposition filed within time limit [1994/43]
Fees paidRenewal fee
23.02.1990Renewal fee patent year 03
19.02.1991Renewal fee patent year 04
14.02.1992Renewal fee patent year 05
13.02.1993Renewal fee patent year 06
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Documents cited:Search[X]EP0088695  (CYTOGEN CORP [US]);
 [X]EP0111388  (INCO RES & DEV CENTER INC [US])
ExaminationEP0099133
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.